Plain-English translation of NCT07360886 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Sclerosis research guide →This research study is looking for people with multiple sclerosis (MS) or Parkinson's disease (PD) who drive to help doctors better assess whether it's safe for them to be behind the wheel. Researchers will have you complete several standard neurological tests—like walking, fine motor tasks, and cognitive assessments—along with specialized computer-based testing. The goal is to figure out which of these tests are most reliable at predicting real-world driving ability, so doctors can eventually use a simple calculator to help make these safety decisions.
Many people with MS or Parkinson's disease want to keep driving safely, but doctors don't have a clear, standardized way to evaluate their driving fitness. This study aims to identify which easy-to-do clinical tests best predict driving safety, so that physicians can have a practical tool—a kind of calculator—to help them make informed recommendations about who can safely continue driving.
You likely qualify if…
You likely don't qualify if…
If you qualify, you'll visit the research center for testing sessions where you'll complete a basic neurological exam, walk a short distance at a set pace, take cognitive tests (like symbol recognition and memory tasks), do fine motor coordination tests (like placing pegs in holes), and use a specialized computer testing system. The whole process takes several hours but is non-invasive—no injections, medications, or procedures. Researchers may also review your medical records to strengthen their findings.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Czechia
Sponsor
University Hospital Olomouc
Collaborators
Palacky University
Enrollment target
~200 participants
Started
November 2025
Primary completion
December 2026
Age range
18 Years – 85 Years
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Dalibor Zimek, M.D.
University Hospital Olomouc
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.